ClinicalTrials.Veeva

Menu
A

Advanced Medical Research Institute | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Olezarsen
MT-2990
AD109

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 6 total trials

A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

The purpose of the study is to evaluate the effect of olezarsen on percent change in fasting triglyceride (TG) levels compared to placebo in particip...

Active, not recruiting
Hypertriglyceridemia
Cardiovascular Diseases
Drug: Placebo
Drug: Olezarsen

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Ob...

Enrolling
OSA
Drug: Placebo
Drug: AD109

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Apnimed logo
Ionis Pharmaceuticals logo
Mitsubishi Tanabe Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems